These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
9. [Refractory gastroesophageal reflux disease (GERD) and PPI safety]. Huerta-Iga FM Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041 [No Abstract] [Full Text] [Related]
10. Pro: Impedance testing is useful in the management of GERD. Blondeau K; Tack J Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230 [No Abstract] [Full Text] [Related]
11. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Sweis R; Anggiansah A; Wong T Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931 [No Abstract] [Full Text] [Related]
12. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux. Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396 [TBL] [Abstract][Full Text] [Related]
13. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles. Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583 [TBL] [Abstract][Full Text] [Related]
15. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study. Moawad FJ; Betteridge JD; Boger JA; Cheng FK; Belle LS; Chen YJ; Maydonovitch CL; Wong RK Aliment Pharmacol Ther; 2013 May; 37(10):1011-8. PubMed ID: 23560727 [TBL] [Abstract][Full Text] [Related]
16. The changing paradigm of GERD. Castell D; Tutuian R Curr Gastroenterol Rep; 2007 Dec; 9(6):441-2. PubMed ID: 18377793 [No Abstract] [Full Text] [Related]
17. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease]. Juhász M; Tulassay Z Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107 [TBL] [Abstract][Full Text] [Related]
18. Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications? Ward MA; Dunst CM; Glasgow ME; Teitelbaum EN; Abdelmoaty WF; Reavis KM; Swanstrӧm LL; DeMeester SR J Gastrointest Surg; 2019 Jul; 23(7):1301-1308. PubMed ID: 30859425 [TBL] [Abstract][Full Text] [Related]
19. Problems of nociception in gastroesophageal reflux disease: diagnostics and treatment of irritated oesophagus. Sablin OA; Ilchishina TA Ter Arkh; 2018 Aug; 90(8):118-124. PubMed ID: 30701946 [TBL] [Abstract][Full Text] [Related]
20. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements. Pohl D; Tutuian R Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]